GIP and bariatric surgery

Obesity Surgery

Volumn 21, Issue 2, 2011, Pages 244-252

  Rao, Raghavendra S ^a   Kini, Subhash ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Bariatric surgery; BPD; GIP; GLP 1; Ileal transposition; LAGB; RYGB; Sleeve gastrectomy; TCF7L2

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; INSULIN;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; DISEASE MODEL; GASTRIC BANDING; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; STOMACH BYPASS; WEIGHT REDUCTION;

ANIMALS; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GASTRIC INHIBITORY POLYPEPTIDE; HUMANS; OBESITY; PEPTIDE FRAGMENTS; WEIGHT LOSS;

EID: 79951727605     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-010-0305-x     Document Type: Review

References (67)

1. CH McIntosh S Widenmaier SJ Kim 2009 Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP) Vitam Horm 80 409 471 1:CAS:528:DC%2BD1MXptlSitLo%3D 10.1016/S0083-6729(08)00615-8 19251046
2. M Lu MB Wheeler XH Leng, et al. 1993 The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I (7-37) Endocrinology 132 94 100 1:CAS:528:DyaK3sXhtFOit7Y%3D 10.1210/en.132.1.94 8380389 (Pubitemid 23019487)
3. EG Siegel W Creutzfeldt 1985 Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content Diabetologia 28 857 861 1:CAS:528:DyaL28Xmt1Gksw%3D%3D 10.1007/BF00291078 2417905 (Pubitemid 16176057)
4. SA Ross J Dupre 1978 Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects Diabetes 27 327 333 1:CAS:528: DyaE1cXhvVOntr4%3D 10.2337/diabetes.27.3.327 640238 (Pubitemid 8311752)
5. JA Ehses VR Casilla T Doty, et al. 2003 Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase Endocrinology 144 4433 4445 1:CAS:528:DC%2BD3sXns1Srur4%3D 10.1210/en.2002-0068 12960055 (Pubitemid 37204843)
6. SJ Kim K Winter C Nian, et al. 2005 Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression J Biol Chem 280 22297 22307 1:CAS:528:DC%2BD2MXksl2ht7w%3D 10.1074/jbc.M500540200 15817464 (Pubitemid 40827886)
7. SJ Kim C Nian S Widenmaier, et al. 2008 Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2 Mol Cell Biol 28 1644 1656 1:CAS:528:DC%2BD1cXivVajtL4%3D 10.1128/MCB.00325-07 18086876
8. W Creutzfeldt 2001 The entero-insular axis in type 2 diabetes-incretins as therapeutic agents Exp Clin Endocrinol Diabetes 109 Suppl 2 S288 S303 1:CAS:528:DC%2BD3MXlslKgu74%3D 10.1055/s-2001-18589 11460578 (Pubitemid 32577588)
9. CI Cheeseman D O'Neill 1998 Basolateral D-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2 Exp Physiol 83 605 616 1:CAS:528:DyaK1cXntFOnsrY%3D 9793781 (Pubitemid 28458392)
10. CI Cheeseman R Tsang 1996 The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport Am J Physiol 271 G477 G482 1:CAS:528:DyaK28XmtFajur8%3D 8843773
11. J Girard 2008 The incretins: from the concept to their use in the treatment of type 2 diabetes. Part A: incretins: concept and physiological functions Diabetes Metab 34 550 559 1:CAS:528:DC%2BD1MXitVWntLw%3D 10.1016/j.diabet.2008.09.001 19036624
12. J Oben L Morgan J Fletcher, et al. 1991 Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue J Endocrinol 130 267 272 1:CAS:528:DyaK3MXkvVGrtrs%3D 10.1677/joe.0.1300267 1919397
13. H Hauner G Glatting D Kaminska, et al. 1988 Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes Ann Nutr Metab 32 282 288 1:CAS:528:DyaL1MXhtVyltL8%3D 10.1159/000177467 3076052 (Pubitemid 19049978)
14. C Yamada Y Yamada K Tsukiyama, et al. 2008 The murine glucagon-like peptide-1 receptor is essential for control of bone resorption Endocrinology 149 574 579 1:CAS:528:DC%2BD1cXht1yqtrg%3D 10.1210/en.2007-1292 18039776 (Pubitemid 351159357)
15. K Tsukiyama Y Yamada C Yamada, et al. 2006 Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion Mol Endocrinol 20 1644 1651 1:CAS:528:DC%2BD28Xms1GjsbY%3D 10.1210/me.2005-0187 16469773 (Pubitemid 43967571)
16. JJ Meier MA Nauck WE Schmidt, et al. 2002 Gastric inhibitory polypeptide: the neglected incretin revisited Regul Pept 107 1 13 1:CAS:528: DC%2BD38Xls1Wls7s%3D 10.1016/S0167-0115(02)00039-3 12137960 (Pubitemid 34876440)
17. T Vilsboll H Agerso T Lauritsen, et al. 2006 The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects Regul Pept 137 168 172 1:CAS:528:DC%2BD28Xht12rsLjP 10.1016/j.regpep.2006.07.007 16934887 (Pubitemid 44838981)
18. K Hupe-Sodmann GP McGregor R Bridenbaugh, et al. 1995 Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides Regul Pept 58 149 156 1:CAS:528:DyaK2MXns1Gls7c%3D 10.1016/0167- 0115(95)00063-H 8577927
19. D Elahi DK Andersen DC Muller, et al. 1984 The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus Diabetes 33 950 957 1:CAS:528: DyaL2cXlvV2hsr8%3D 10.2337/diabetes.33.10.950 6383904 (Pubitemid 14013927)
20. T Vilsboll T Krarup J Sonne, et al. 2003 Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus J Clin Endocrinol Metab 88 2706 2713 1:CAS:528: DC%2BD3sXkslCrs7s%3D 10.1210/jc.2002-021873 12788877 (Pubitemid 36724446)
21. K Miyawaki Y Yamada N Ban, et al. 2002 Inhibition of gastric inhibitory polypeptide signaling prevents obesity Nat Med 8 738 742 1:CAS:528: DC%2BD38XkvFehtrY%3D 10.1038/nm727 12068290 (Pubitemid 34778728)
22. MJ Theodorakis O Carlson DC Muller, et al. 2004 Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance Diabetes Care 27 1692 1698 1:CAS:528: DC%2BD2cXmt1CmtL0%3D 10.2337/diacare.27.7.1692 15220248 (Pubitemid 38857446)
23. FK Knop T Vilsboll PV Hojberg, et al. 2007 The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance Regul Pept 144 123 130 1:CAS:528:DC%2BD2sXht12gtbzE 10.1016/j.regpep.2007.07.002 17692937 (Pubitemid 350030308)
24. FC Lynn N Pamir EH Ng, et al. 2001 Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats Diabetes 50 1004 1011 1:CAS:528:DC%2BD3MXkvFSgur8%3D 10.2337/diabetes.50.5.1004 11334402 (Pubitemid 32374530)
25. S Piteau A Olver SJ Kim, et al. 2007 Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat Biochem Biophys Res Commun 362 1007 1012 1:CAS:528:DC%2BD2sXhtVGisbnN 10.1016/j.bbrc.2007.08.115 17803965 (Pubitemid 47398873)
26. FK Knop T Vilsboll PV Hojberg, et al. 2007 Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state Diabetes 56 1951 1959 1:CAS:528:DC%2BD2sXos12qsro%3D 10.2337/db07-0100 17513701 (Pubitemid 47195814)
27. JJ Meier K Hucking JJ Holst, et al. 2001 Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes Diabetes 50 2497 2504 1:CAS:528:DC%2BD3MXotFGisrk%3D 10.2337/diabetes.50.11.2497 11679427 (Pubitemid 33642767)
28. T Vilsboll T Krarup S Madsbad, et al. 2002 Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients Diabetologia 45 1111 1119 1:CAS:528:DC%2BD38Xmt1ShsrY%3D 10.1007/s00125-002-0878-6 12189441 (Pubitemid 34985287)
29. K Pilgaard CB Jensen JH Schou, et al. 2009 The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men Diabetologia 52 1298 1307 1:CAS:528:DC%2BD1MXms1yhs70%3D 10.1007/s00125-009-1307-x 19288077
30. D Gniuli A Calcagno LL Dalla, et al. 2010 High-fat feeding stimulates endocrine, glucose-dependent insulinotropic polypeptide (GIP)-expressing cell hyperplasia in the duodenum of Wistar rats Diabetologia 53 2233 2240 1:CAS:528:DC%2BC3cXhtV2gtrbM 10.1007/s00125-010-1830-9 20585935
31. JM Rijkelijkhuizen K McQuarrie CJ Girman, et al. 2010 Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses Metabolism 59 502 511 1:CAS:528:DC%2BC3cXjslSrsrw%3D 10.1016/j.metabol.2009.07.039 19846181
32. M Rudnicki DG Patel DW McFadden, et al. 1990 Proximal jejunal and biliary effects on the enteroinsular axis Surgery 107 455 460 1:STN:280: DyaK3c3gvVKgtQ%3D%3D 2181717 (Pubitemid 20135404)
33. F Rubino 2008 Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis Diabetes Care 31 Suppl 2 S290 S296 10.2337/dc08-s271 18227499
34. MV de Campos Martins AA Peixoto A Schanaider, et al. 2009 Glucose tolerance in the proximal versus the distal small bowel in Wistar rats Obes Surg 19 202 206 10.1007/s11695-008-9651-3 18719969
35. TJ Little S Doran JH Meyer, et al. 2006 The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed Am J Physiol Endocrinol Metab 291 E647 E655 1:CAS:528: DC%2BD28XhtVSlu7bK 10.1152/ajpendo.00099.2006 16684852 (Pubitemid 44352273)
36. F Rubino A Forgione DE Cummings, et al. 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 741 749 10.1097/01.sla.0000224726.61448.1b 17060767 (Pubitemid 44629948)
37. GA Cote SA Edmundowicz 2009 Emerging technology: endoluminal treatment of obesity Gastrointest Endosc 70 991 999 10.1016/j.gie.2009.09.016 19879407
38. TT Wang SY Hu HD Gao, et al. 2008 Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1 Ann Surg 247 968 975 10.1097/SLA.0b013e318172504d 18520224 (Pubitemid 351770417)
39. WJ Pories RJ Albrecht 2001 Etiology of type II diabetes mellitus: role of the foregut World J Surg 25 527 531 1:STN:280:DC%2BD3M3kt1eqtA%3D%3D 10.1007/s002680020348 11344408 (Pubitemid 32455209)
40. S Santoro 2008 Is the metabolic syndrome a disease of the foregut? Yes, excessive foregut Ann Surg 247 1074 1075 10.1097/SLA.0b013e3181758ddb 18520238 (Pubitemid 351770431)
41. TL Kindel SM Yoder DA D'Alessio, et al. 2010 The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats Obes Surg 20 768 775 10.1007/s11695-010-0095-1 20177809
42. AD Strader TP Vahl RJ Jandacek, et al. 2005 Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats Am J Physiol Endocrinol Metab 288 E447 E453 1:CAS:528: DC%2BD2MXhsVCktLo%3D 10.1152/ajpendo.00153.2004 15454396 (Pubitemid 40110655)
43. F Rubino J Marescaux 2004 Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Ann Surg 239 1 11 10.1097/01.sla.0000102989.54824.fc 14685093 (Pubitemid 38176365)
44. D Pacheco DA de Luis A Romero, et al. 2007 The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats Am J Surg 194 221 224 1:CAS:528:DC%2BD2sXnsFWmtbY%3D 10.1016/j.amjsurg.2006.11.015 17618808 (Pubitemid 47008973)
45. PL McClean N Irwin K Hunter, et al. 2008 (Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy Br J Pharmacol 155 690 701 1:CAS:528:DC%2BD1cXht12lsrnF 10.1038/bjp.2008.317 18695644
46. PR Flatt 2008 Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes? Diabet Med 25 759 764 1:CAS:528:DC%2BD1cXpvFyitbk%3D 10.1111/j.1464-5491.2008. 02455.x 18513308
47. BA Whitson DB Leslie TA Kellogg, et al. 2007 Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study J Surg Res 141 31 39 1:CAS:528:DC%2BD2sXmsFCrt7s%3D 10.1016/j.jss.2007.02.022 17574036 (Pubitemid 46898439)
48. J Korner M Bessler W Inabnet, et al. 2007 Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding Surg Obes Relat Dis 3 597 5601 10.1016/j.soard.2007.08.004 17936091 (Pubitemid 350091417)
49. F Rubino M Gagner P Gentileschi, et al. 2004 The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 236 242 10.1097/01.sla.0000133117.12646.48 15273546 (Pubitemid 38963013)
50. RH Clements QH Gonzalez CI Long, et al. 2004 Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus Am Surg 70 1 4 14964537
51. B Laferrere J Teixeira J McGinty, et al. 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 2479 2485 1:CAS:528:DC%2BD1cXoslyktb8%3D 10.1210/jc.2007-2851 18430778 (Pubitemid 352008510)
52. B Laferrere S Heshka K Wang, et al. 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709 1716 1:CAS:528: DC%2BD2sXotlWhsbw%3D 10.2337/dc06-1549 17416796 (Pubitemid 47036341)
53. C Guidone M Manco E Valera-Mora, et al. 2006 Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Diabetes 55 2025 2031 1:CAS:528:DC%2BD28XmvVChtL4%3D 10.2337/db06-0068 16804072 (Pubitemid 44509976)
54. G Mingrone G Nolfe GC Gissey, et al. 2009 Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion Diabetologia 52 873 881 1:CAS:528:DC%2BD1MXktVOrsb8%3D 10.1007/s00125-009-1288-9 19229515
55. S Salinari A Bertuzzi S Asnaghi, et al. 2009 First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery Diabetes Care 32 375 380 1:CAS:528:DC%2BD1MXjvVyqsbs%3D 10.2337/dc08-1314 19033407
56. JR Shak J Roper GI Perez-Perez, et al. 2008 The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones Obes Surg 18 1089 1096 10.1007/s11695-008-9454-6 18408980
57. AL DePaula AL Macedo V Schraibman, et al. 2009 Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34 Surg Endosc 23 1724 1732 10.1007/s00464-008-0168-6 18830747
58. 2: a report of 2 cases Surg Obes Relat Dis 3 195 197 10.1016/j.soard.2007.01.009 17386401 (Pubitemid 46444706)
59. HC Lee MK Kim HS Kwon, et al. 2010 Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients Obes Surg 20 1530 1535 10.1007/s11695-010-0248-2 20803098
60. E Naslund L Backman JJ Holst, et al. 1998 Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity Obes Surg 8 253 260 1:STN:280:DyaK1czktlWlsQ%3D%3D 10.1381/096089298765554449 9678192 (Pubitemid 28334120)
61. L Ockander JL Hedenbro JF Rehfeld, et al. 2003 Jejunoileal bypass changes the duodenal cholecystokinin and somatostatin cell density Obes Surg 13 584 590 10.1381/096089203322190781 12935359 (Pubitemid 36951737)
62. M Guldstrand B Ahren E Naslund, et al. 2009 Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery Diabetes Obes Metab 11 1027 1033 1:STN:280:DC%2BD1MnlsV2hsg%3D%3D 10.1111/j.1463-1326.2009.01089.x 19614945
63. R Peterli B Wolnerhanssen T Peters, et al. 2009 Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial Ann Surg 250 234 241 10.1097/SLA.0b013e3181ae32e3 19638921
64. CF Deacon MA Nauck J Meier, et al. 2000 Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide J Clin Endocrinol Metab 85 3575 3581 1:CAS:528:DC%2BD3cXnsFOgtrg%3D 10.1210/jc.85.10.3575 11061504
65. MA Nauck MM Heimesaat K Behle, et al. 2002 Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers J Clin Endocrinol Metab 87 1239 1246 1:CAS:528:DC%2BD38XitlWnsro%3D 10.1210/jc.87.3.1239 11889194 (Pubitemid 36121094)
66. N Imeryuz BC Yegen A Bozkurt, et al. 1997 Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms Am J Physiol 273 G920 G927 1:CAS:528:DyaK2sXnt1Srs7o%3D 9357836
67. V Sancho MV Trigo A Martin-Duce, et al. 2006 Effect of GLP-1 on D-glucose transport, lipolysis and lipogenesis in adipocytes of obese subjects Int J Mol Med 17 1133 1137 1:CAS:528:DC%2BD28XmtFags7Y%3D 16685426